Stockscreener 앱 받기
47.42
2.60%
-1.2159
전일 마감가:
$48.64
열려 있는:
$48.82
하루 거래량:
171.44K
Relative Volume:
2.84
시가총액:
$229.97M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-3.32%
1개월 성능:
+0.14%
6개월 성능:
+29.26%
1년 성능:
+8.11%
1일 변동 폭
$47.17
$48.82
1주일 범위
$47.17
$49.21
52주 변동 폭
$35.22
$49.31
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
XPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
47.42 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
323.90 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
657.48 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
660.74 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
249.65 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
594.56 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf 주식(XPH)의 최신 뉴스
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - sharewise.com
INCY and ABBV lead S&P 500 healthcare gainers in Q3; MOH and ALGN lag - MSN
Pharma stocks at 15-year valuation lows may offer value – BMO’s Evan Seigerman - Seeking Alpha
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
P Pharmaceuticals ETF stock return to pre crash levelsWatch List & Safe Entry Point Identification - newser.com
P Pharmaceuticals ETF stock beat international competitionQuarterly Earnings Summary & Long-Term Safe Investment Ideas - newser.com
6 Best Health Care Funds and ETFs for 2025 - US News Money
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
P Pharmaceuticals ETF stock protected from inflationWeekly Volume Report & Capital Protection Trade Alerts - newser.com
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
P Pharmaceuticals ETF stock prepared for digital transitionTrade Analysis Summary & Capital Efficiency Focused Strategies - newser.com
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff - inkl
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - Yahoo Finance
SPDR S&P Biotech ETF (XBI) Top 25 Holdings - TIKR.com
SPDR S&P Pharmaceuticals ETF $XPH Stake Boosted by Goldman Sachs Group Inc. - Defense World
Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most shorted stock - Seeking Alpha
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
The Best Health Care ETFs to Buy - Kiplinger
XLV Vs. IHE: Will Pharmaceuticals Outperform Healthcare? (NYSEARCA:XLV) - Seeking Alpha
Simplex Trading LLC Buys Shares of 627 SPDR S&P Pharmaceuticals ETF $XPH - Defense World
Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy. - inkl
SPDR S&P Pharmaceuticals ETF $XPH Stock Position Reduced by Cetera Investment Advisers - Defense World
PJP: Healthcare Dashboard For August (NYSEARCA:PJP) - Seeking Alpha
Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock - MSN
Market Voices: Bessent clarifies Fed comments, pharma tariffs, Target - Seeking Alpha
Blair William & Co. IL Buys Shares of 686 SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)? - Yahoo Finance
Blair William & Co. IL Purchases 251 Shares of Vanguard S&P Mid-Cap 400 ETF (NYSEARCA:IVOO) - Defense World
XTX Topco Ltd Invests $204,000 in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
LPL Financial LLC Decreases Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Cetera Investment Advisers Increases Holdings in SPDR S&P Fossil Fuel Reserves Free ETF (NYSEARCA:SPYX) - Defense World
7 Best Biotech ETFs to Buy Now - US News Money
Investors Purchase High Volume of Call Options on SPDR S&P Regional Banking ETF (NYSEARCA:KRE) - Defense World
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
PNC Financial Services Group Inc. Sells 917 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
SPYX ETF Can Reach $58, Analysts Say - AInvest
Envestnet Asset Management Inc. Sells 1,028 Shares of SPDR S&P 500 ESG ETF (NYSEARCA:EFIV) - Defense World
SPDR S&P 400 Mid Cap Growth ETF (NYSEARCA:MDYG) Sees Significant Increase in Short Interest - Defense World
Spdr Pharmaceuticals Etf (XPH) 재무 분석
Spdr Pharmaceuticals Etf (XPH)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.36%
자본화:
|
볼륨(24시간):